DK1161449T3 - Modulatorer af beta-amyloidpeptidaggregering, der omfatter d-aminosyrer - Google Patents

Modulatorer af beta-amyloidpeptidaggregering, der omfatter d-aminosyrer

Info

Publication number
DK1161449T3
DK1161449T3 DK00916028T DK00916028T DK1161449T3 DK 1161449 T3 DK1161449 T3 DK 1161449T3 DK 00916028 T DK00916028 T DK 00916028T DK 00916028 T DK00916028 T DK 00916028T DK 1161449 T3 DK1161449 T3 DK 1161449T3
Authority
DK
Denmark
Prior art keywords
peptide
amyloid peptide
group
compounds
amino
Prior art date
Application number
DK00916028T
Other languages
Danish (da)
English (en)
Inventor
Mark A Findeis
Kathryn Phillips
Gary L Olson
Christopher Self
Original Assignee
Praecis Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Praecis Pharm Inc filed Critical Praecis Pharm Inc
Application granted granted Critical
Publication of DK1161449T3 publication Critical patent/DK1161449T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00916028T 1999-03-04 2000-03-03 Modulatorer af beta-amyloidpeptidaggregering, der omfatter d-aminosyrer DK1161449T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12273699P 1999-03-04 1999-03-04
PCT/US2000/005574 WO2000052048A1 (en) 1999-03-04 2000-03-03 Modulators of beta-amyloid peptide aggregation comprising d-amino acids

Publications (1)

Publication Number Publication Date
DK1161449T3 true DK1161449T3 (da) 2007-11-05

Family

ID=22404455

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00916028T DK1161449T3 (da) 1999-03-04 2000-03-03 Modulatorer af beta-amyloidpeptidaggregering, der omfatter d-aminosyrer

Country Status (19)

Country Link
US (3) US6610658B1 (xx)
EP (1) EP1161449B1 (xx)
JP (2) JP2002543043A (xx)
KR (1) KR100771712B1 (xx)
CN (1) CN1279053C (xx)
AT (1) ATE366259T1 (xx)
AU (1) AU781292B2 (xx)
BR (1) BR0008738A (xx)
CA (1) CA2362834C (xx)
CY (1) CY1106899T1 (xx)
DE (1) DE60035412T2 (xx)
DK (1) DK1161449T3 (xx)
ES (1) ES2290023T3 (xx)
HK (1) HK1040722B (xx)
NZ (1) NZ514414A (xx)
PT (1) PT1161449E (xx)
RU (1) RU2260599C2 (xx)
WO (1) WO2000052048A1 (xx)
ZA (1) ZA200107913B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277826B1 (en) * 1996-08-27 2001-08-21 Praecis Pharmaceuticals, Inc. Modulators of β-amyloid peptide aggregation comprising D-amino acids
WO1997021728A1 (en) 1995-12-12 1997-06-19 Karolinska Innovations Ab PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b)
DE60035412T2 (de) * 1999-03-04 2008-02-14 Praecis Pharmaceuticals, Inc., Cambridge Beta-amyloid-peptidaggregation regulierende peptide mit d-aminosäuren
US7060670B1 (en) * 1999-05-05 2006-06-13 Neurochem (International) Limited Stereoselective antifibrillogenic peptides and peptidomimetics thereof
GB9917725D0 (en) * 1999-07-28 1999-09-29 Medical Res Council Peptides
US20070135337A2 (en) * 1999-11-29 2007-06-14 Neurochem (International) Limited Vaccine for the Prevention and Treatment of Alzheimer's and Amyloid Related Diseases
US20020094335A1 (en) * 1999-11-29 2002-07-18 Robert Chalifour Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
AU3808801A (en) * 2000-02-11 2001-08-20 Praecis Pharmaceuticals Incorporated Methods for enhancing the bioavailability of a drug
AUPR215700A0 (en) * 2000-12-19 2001-01-25 Fujisawa Pharmaceutical Co., Ltd. Carboxylic acid compound having cyclopropane ring
DE10117281A1 (de) * 2001-04-06 2002-10-24 Inst Molekulare Biotechnologie Peptid zur Diagnose und Therapie der Alzheimer-Demenz
JP4435574B2 (ja) 2002-04-18 2010-03-17 イエダ リサーチ アンド ディベロップメント カンパニー リミテッド ＩＬ−２レセプターγ鎖の誘導体、その製法および使用
AU2003292936A1 (en) * 2002-12-24 2004-07-22 Neurochem (International) Limited Therapeutic formulations for the treatment of beta-amyloid related diseases
CN100340599C (zh) * 2003-06-09 2007-10-03 湖南大学 多聚赖氨酸淀粉纳米颗粒与制备方法及作为基因载体的应用
GB0503434D0 (en) * 2005-02-18 2005-03-30 Senexis Ltd Amyloid-binding peptides, analogues and uses thereof
PE20100748A1 (es) * 2005-12-12 2010-11-12 Hoffmann La Roche Anticuerpo anti beta-4-amiloide que contiene asparagina glicosilada en la region variable de vh
JP2010518064A (ja) 2007-02-12 2010-05-27 メルク・シャープ・エンド・ドーム・コーポレイション Ａｄおよび関連状態の治療のためのピペラジン誘導体
DE102008037564A1 (de) * 2008-11-19 2010-05-20 Forschungszentrum Jülich GmbH Zusammensetzung zur Herstellung von anti-Amyloid beta-Peptid-Antikörpern mit D-Peptiden
KR101974044B1 (ko) * 2009-12-07 2019-04-30 피어이스 파마슈티컬즈 게엠베하 주어진 표적에 대한 친화성을 갖는 인간의 리포칼린 2의 뮤테인
US10653631B2 (en) 2011-09-07 2020-05-19 Roland SAUR-BROSCH Optimal colon targeting technology
WO2013035081A2 (de) 2011-09-07 2013-03-14 JÄNISCH, Melisa Optimale formulierung zur freisetzung eines wirkstoffes im dickdarm
KR101437354B1 (ko) * 2012-07-27 2014-09-05 한국과학기술연구원 고수율 및 고순도의 아밀로이드-베타 펩타이드의 제조방법
KR20230128606A (ko) * 2022-02-28 2023-09-05 경상국립대학교산학협력단 티로신을 유효성분으로 함유하는 알츠하이머병의 예방, 개선 또는 치료용 조성물

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR82516E (fr) * 1962-10-11 1964-02-28 Ciba Geigy Procédé de préparation de dérivés peptidiques, notamment d'hydrazides peptidiques
US4119493A (en) 1975-10-23 1978-10-10 (Zaidanhojin) Sagami Chemical Research Center Process for producing a peptide
US5284664A (en) 1988-08-04 1994-02-08 Kremers-Urban Company Method of treating the symptoms of Alzheimer's disease
US5652214A (en) 1989-06-05 1997-07-29 Cephalon, Inc. Treating disorders by application of insulin-like growth factors and analogs
US5338663A (en) 1990-08-24 1994-08-16 President And Fellows Of Harvard College Method of identifying inhibitors of β-protein esterase activity
US5434050A (en) 1991-08-13 1995-07-18 Regents Of The University Of Minnesota Labelled β-amyloid peptide and methods of screening for Alzheimer's disease
US5338837A (en) 1991-12-13 1994-08-16 The Trustees Of Princeton University Glycosylated steroid derivatives for transport across biological membranes and process for making same
US5766846A (en) 1992-07-10 1998-06-16 Athena Neurosciences Methods of screening for compounds which inhibit soluble β-amyloid peptide production
US6120768A (en) 1993-05-17 2000-09-19 Immunomedics, Inc. Dota-biotin derivatives
WO1994028412A1 (en) 1993-05-28 1994-12-08 The Miriam Hospital Composition and method for in vivo imaging of amyloid deposits
US5541290A (en) 1993-06-24 1996-07-30 Harbeson; Scott L. Optically pure calpain inhibitor compounds
CA2125467C (en) 1993-07-06 2001-02-06 Heinz Dobeli Process for producing hydrophobic polypeptides, proteins or peptides
AU7556994A (en) 1993-08-13 1995-03-14 Molecular Geriatrics Corporation Methods for the diagnosis of alzheimer's disease
GB9317120D0 (en) 1993-08-17 1993-09-29 Royal Postgrad Med School Human serum amyloid p component
US5652334A (en) 1993-09-08 1997-07-29 City Of Hope Method for design of substances that enhance memory and improve the quality of life
US5470951A (en) 1993-09-29 1995-11-28 City Of Hope Peptides for antagonizing the effects of amyloid βprotein
US5744368A (en) 1993-11-04 1998-04-28 Research Foundation Of State University Of New York Methods for the detection of soluble amyloid β-protein (βAP) or soluble transthyretin (TTR)
JPH07149668A (ja) 1993-11-30 1995-06-13 Kanegafuchi Chem Ind Co Ltd アミロイド沈着検出用物質
US5935927A (en) 1994-02-03 1999-08-10 The Picower Institute For Medical Research Compositions and methods for stimulating amyloid removal in amyloidogenic diseases using advanced glycosylation endproducts
EP0815134B1 (en) * 1995-03-14 2002-06-05 Praecis Pharmaceuticals Incorporated Modulators of amyloid aggregation
US6303567B1 (en) * 1995-03-14 2001-10-16 Praecis Pharmaceuticals, Inc . Modulators of β-amyloid peptide aggregation comprising D-amino acids
US5767233A (en) 1995-05-12 1998-06-16 Schering Corporation Soluble cleavable substrates of the hepatitis C virus protease
US5985242A (en) 1995-10-27 1999-11-16 Praecis Pharmaceuticals, Inc. Modulators of β-amyloid peptide aggregation comprising D-amino acids
US6277826B1 (en) * 1996-08-27 2001-08-21 Praecis Pharmaceuticals, Inc. Modulators of β-amyloid peptide aggregation comprising D-amino acids
WO1997021728A1 (en) * 1995-12-12 1997-06-19 Karolinska Innovations Ab PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b)
DK0929574T3 (da) 1996-08-27 2005-10-31 Praecis Pharm Inc Modulatorer af beta-amyloidpeptidaggregering, som omfatter D-aminosyrer
DE60035412T2 (de) * 1999-03-04 2008-02-14 Praecis Pharmaceuticals, Inc., Cambridge Beta-amyloid-peptidaggregation regulierende peptide mit d-aminosäuren

Also Published As

Publication number Publication date
JP2011121952A (ja) 2011-06-23
KR100771712B1 (ko) 2007-10-30
HK1040722B (zh) 2008-02-22
PT1161449E (pt) 2007-10-12
DE60035412D1 (de) 2007-08-16
HK1040722A1 (en) 2002-06-21
CY1106899T1 (el) 2012-09-26
ZA200107913B (en) 2002-11-27
WO2000052048A9 (en) 2002-04-11
CN1279053C (zh) 2006-10-11
JP2002543043A (ja) 2002-12-17
CA2362834A1 (en) 2000-09-08
ES2290023T3 (es) 2008-02-16
US20050137128A1 (en) 2005-06-23
DE60035412T2 (de) 2008-02-14
KR20020007316A (ko) 2002-01-26
CN1362967A (zh) 2002-08-07
NZ514414A (en) 2004-02-27
US6610658B1 (en) 2003-08-26
US20030236197A1 (en) 2003-12-25
RU2260599C2 (ru) 2005-09-20
ATE366259T1 (de) 2007-07-15
US7803774B2 (en) 2010-09-28
EP1161449A1 (en) 2001-12-12
EP1161449B1 (en) 2007-07-04
WO2000052048A1 (en) 2000-09-08
CA2362834C (en) 2005-12-06
BR0008738A (pt) 2001-12-26
US6831066B2 (en) 2004-12-14
AU3719600A (en) 2000-09-21
AU781292B2 (en) 2005-05-12

Similar Documents

Publication Publication Date Title
CY1106899T1 (el) Διαμορφωτες συσσωματωσης βητα-αμυλοειδων πεπτιδιων που περιλαμβανουν d-αμινοξεα
DK0929574T3 (da) Modulatorer af beta-amyloidpeptidaggregering, som omfatter D-aminosyrer
AR023208A1 (es) Nutraceuticos con 1-metil ester de n-[n-3,3-dimetilbutil)-l-alfa-aspartil]-l-fenilalanina
DE69713112D1 (de) Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin-analogen
DE69635493D1 (de) Verfahren zur herstellung von l-aminosäuren
ATE406383T1 (de) Verkürzte tau proteine
ATE417925T1 (de) Verfahren zur präsentation von (poly)peptiden/proteinen auf bakteriophagenpartikeln via disulfidbindungen
DE69531204D1 (de) Formulierungen fuer faktor ix
BR9707819A (pt) Imunogenos peptidicos
DE69636453D1 (de) Modulation der aktivität des cholesteryl-ester-transfer-proteins (cetp)
ATE384077T1 (de) Stereoselektive antifibrillogene peptide
DE60023860D1 (de) Verfahren zur herstellung von rekombinanten peptiden
ATE331037T1 (de) Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff
ATE290315T1 (de) Von humanem hitzeschockprotein 60 hergeleitete peptide zur behandlung von diabetis, entsprechende zusammensetzungen, verfahren und kits
PT896615E (pt) Peptido proveniente de uma forma soluvel de acetilcolinesterase activo como modulador dos canais de calcio
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
EP1080724A4 (en) COMPOSITIONS FOR REDUCING MTP ACTIVITY
DE60017290D1 (de) Neue methoden zur herstellung von p-phenylendiaminen
DK0946590T3 (da) Dihydroxypropylcysteinpeptid og middel, der indeholder dette peptid
DE69413637D1 (de) Verwendung von verzweigtkettigen Aminosäuren zur Herstellung eines Arzneimittels zur Behandlung von tardiver Dyskinesia
EP1870419A3 (en) Modulators of beta-amyloid peptide aggregation comprising d-amino acids
ATE346091T1 (de) Neues diagnostisches reagens und kit zur erkennung von rickettsiose
AR026068A1 (es) Peptidos modificados y peptidomimeticos para el uso en inmunoterapia.
MX9206339A (es) Nueva proteina inhibidora de trombina a partir de chinches de monte
FI973551A0 (fi) Vaetska foer fukt/sprejavkylningsanlaeggningar